Domain Specificity of Anti-Prothrombin Antibodies That Express Lupus Anticoagulant Activity

被引：0
|
作者：
Gehlen, Rachel [1 ]
Noordermeer, Tessa [2 ]
Vandevelde, Arne [3 ,4 ]
Chayoua, Walid [1 ,5 ]
Ninivaggi, Marisa [6 ]
De Laat-Kremers, Romy [7 ]
Roest, Mark [8 ]
De Groot, Philip G. [1 ]
Devreese, Katrien M. J. [3 ,4 ]
Urbanus, Rolf T. [2 ]
De laat, Bas [6 ]
机构：
[1] Synapse Res Inst, Maastricht, Netherlands
[2] Univ Med Ctr Utrecht, Van Kreveldklin, Utrecht, Netherlands
[3] Ghent Univ Hosp, Coagulat Lab, Ghent, Belgium
[4] Univ Ghent, Dept Diag Sci, Ghent, Belgium
[5] Med Spectrum Twente, Enschede, Netherlands
[6] Synapse Res Inst, Dept Funct Coagulat, Maastricht, Netherlands
[7] Synapse Res Inst, Dept Data Anal & Artificial Intelligence, Maastricht, Netherlands
[8] Synapse Res Inst, Dept Platelet Pathophysiol, Maastricht, Netherlands
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185610
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] ANTI-PROTHROMBIN ANTIBODIES AND THE LUPUS ANTICOAGULANT
    FLECK, RA
    RAPAPORT, SI
    RAO, LVM
    BLOOD, 1988, 72 (02) : 512 - 519
  • [2] Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant
    de Groot, PG
    Horbach, DA
    Simmelink, MJA
    van Oort, E
    Derksen, RHWM
    LUPUS, 1998, 7 : S32 - S36
  • [3] Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)
    Pengo, V.
    Denas, G.
    Bison, E.
    Banzato, A.
    Jose, S. Padayattil
    Gresele, P.
    Marongiu, F.
    Erba, N.
    Veschi, F.
    Ghirarduzzi, A.
    De Candia, E.
    Montaruli, B.
    Marietta, M.
    Testa, S.
    Barcellona, D.
    Tripodi, A.
    THROMBOSIS RESEARCH, 2010, 126 (02) : 150 - 153
  • [4] The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant
    Sailer, Thomas
    Vormittag, Rainer
    Zoghlami, Claudia
    Koder, Silvia
    Quehenberger, Peter
    Male, Christoph
    Pabinger, Ingrid
    THROMBOSIS RESEARCH, 2007, 120 (02) : 295 - 302
  • [5] Immunological and anticoagulant properties of anti-prothrombin (LA) antibodies
    Galli, M
    Ruggeri, L
    Daldossi, M
    Beretta, G
    Bevers, EM
    Barbui, T
    THROMBOSIS AND HAEMOSTASIS, 1997, : OC685 - OC685
  • [6] Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces
    Simmelink, MJA
    Horbach, DA
    Derksen, RHWM
    Meijers, JCM
    Bevers, EM
    Willems, GM
    De Groot, PG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) : 621 - 629
  • [7] Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus
    Nojima, J
    Kuratsune, H
    Suehisa, E
    Futsukaichi, Y
    Yamanishi, H
    Machii, T
    Kitani, T
    Iwatani, Y
    Kanakura, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) : 647 - 654
  • [8] Lupus anticoagulant associated with anti-prothrombin auto-antibody
    Duchemin, J
    BaderMeunier, B
    DOiron, R
    Bezeaud, A
    Tchernia, G
    Dreyfus, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2197 - P2197
  • [9] Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies
    Galli, M
    Beretta, G
    Daldossi, M
    Bevers, EM
    Barbui, T
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (03) : 486 - 491
  • [10] Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus
    Nojima, J
    Kuratsune, H
    Suehisa, E
    Kawasaki, T
    Machii, T
    Kitani, T
    Kanakura, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (02) : 577 - 583
12345